Refine
Has Fulltext
- no (5)
Document Type
- Other (5) (remove)
Language
- English (5)
Is part of the Bibliography
- yes (5)
Keywords
- Assays (1)
- Biological Assay (1)
- CKD (1)
- DPP-4 inhibitors (1)
- Dipeptidyl peptidase IV (1)
- PTH (1)
- acute kidney injury (1)
- gliptins (1)
- ischemia reperfusion injury (1)
- oxidative stress (1)
Institute
- Institut für Ernährungswissenschaft (5) (remove)
DPP4 inhibition prevents AKI
(2017)
New data from the LEADER trial show that the glucagon-like peptide 1 receptor agonist liraglutide protects against diabetic nephropathy in patients with type 2 diabetes mellitus. The renoprotective efficacy of liraglutide is not, however, as great as that reported for the sodium-glucose cotransporter 2 inhibitor emplagiflozin in the EMPA-REG OUTCOME trial.